Bionano Genomics
BNGO
149 hedge funds and large institutions have $227M invested in Bionano Genomics in 2021 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 60 increasing their positions, 32 reducing their positions, and 26 closing their positions.
88% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 32
68% more call options, than puts
Call options by funds: $14.3M | Put options by funds: $8.53M
1% more funds holding
Funds holding: 147 → 149 (+2)
8% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 26
0% more ownership
Funds ownership: 0.04% → 0.04% (+0%)
43% less capital invested
Capital invested by funds: $398M → $227M (-$171M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$14.3M |
| 2 |
Morgan Stanley
New York
|
+$3.87M |
| 3 |
Principal Financial Group
Des Moines,
Iowa
|
+$3.58M |
| 4 |
Millennium Management
New York
|
+$2.67M |
| 5 |
EGM
Engineers Gate Manager
New York
|
+$2.64M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank Julius Baer & Co
Zurich,
Switzerland
|
-$9.93M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
-$5.35M |
| 3 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$2.9M |
| 4 |
PVI
Pura Vida Investments
New York
|
-$2.75M |
| 5 |
WG
Winton Group
London,
United Kingdom
|
-$2.7M |
BNGO Hedge Fund Activity: Q4 2021 in Review
149 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q4 2021, worth a combined $227M — down 43% from $398M a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new BNGO positions and 26 closed out — a net gain of 2 holders — while 60 added to existing stakes and 32 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $14.3M. The largest seller was Bank Julius Baer & Co, cutting an estimated $9.93M.
- 149 institutional investors held Bionano Genomics (BNGO) as of Q4 2021, up from 147 in Q3 2021.
- Funds reported $227M of Bionano Genomics stock for Q4 2021, down 43% quarter-over-quarter.
- 28 funds opened new Bionano Genomics positions in Q4 2021 and 26 closed out, a net change of +2 holders.
- The largest Bionano Genomics buyer in Q4 2021 was Citadel Advisors, an estimated $14.3M added.
- The largest Bionano Genomics seller in Q4 2021 was Bank Julius Baer & Co, an estimated $9.93M sold.
Based on aggregated 13F filings for Q4 2021.